Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals ROA 2011-2025 | AVDL

Current and historical return on assets (ROA) values for Avadel Pharmaceuticals (AVDL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Avadel Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-09-30 $0.00B $0.20B 0.00%
2025-06-30 $0.00B $0.19B -1.77%
2025-03-31 $-0.03B $0.17B -16.67%
2024-12-31 $-0.05B $0.16B -30.25%
2024-09-30 $-0.07B $0.16B -44.99%
2024-06-30 $-0.11B $0.16B -61.10%
2024-03-31 $-0.16B $0.17B -84.67%
2023-12-31 $-0.16B $0.17B -90.14%
2023-09-30 $-0.16B $0.20B -93.22%
2023-06-30 $-0.14B $0.20B -91.47%
2023-03-31 $-0.14B $0.14B -97.58%
2022-12-31 $-0.14B $0.13B -82.67%
2022-09-30 $-0.13B $0.15B -67.88%
2022-06-30 $-0.13B $0.16B -59.78%
2022-03-31 $-0.09B $0.22B -35.47%
2021-12-31 $-0.08B $0.25B -28.33%
2021-09-30 $-0.07B $0.26B -22.92%
2021-06-30 $-0.06B $0.28B -18.42%
2021-03-31 $-0.01B $0.29B -1.57%
2020-12-31 $0.01B $0.31B 2.35%
2020-09-30 $0.02B $0.33B 5.84%
2020-06-30 $0.02B $0.34B 8.41%
2020-03-31 $-0.02B $0.21B -12.92%
2019-12-31 $-0.03B $0.15B -21.02%
2019-09-30 $-0.10B $0.16B -55.39%
2019-06-30 $-0.10B $0.17B -51.06%
2019-03-31 $-0.10B $0.17B -41.38%
2018-12-31 $-0.10B $0.19B -34.36%
2018-09-30 $-0.04B $0.27B -13.34%
2018-06-30 $0.00B $0.30B -0.34%
2018-03-31 $0.03B $0.35B 10.87%
2017-12-31 $0.07B $0.25B 26.34%
2017-09-30 $0.08B $0.28B 31.54%
2017-06-30 $0.04B $0.26B 15.83%
2017-03-31 $-0.01B $0.26B -3.59%
2016-12-31 $-0.04B $0.25B -16.43%
2016-09-30 $0.03B $0.25B 12.40%
2016-06-30 $0.02B $0.25B 12.22%
2016-03-31 $0.03B $0.26B 15.22%
2015-12-31 $0.04B $0.22B 29.25%
2015-09-30 $-0.06B $0.00B -43.88%
2015-06-30 $-0.04B $0.19B -23.63%
2015-03-31 $-0.05B $0.19B -26.32%
2014-12-31 $-0.09B $0.17B -48.92%
2014-09-30 $-0.05B $0.16B -33.28%
2014-06-30 $-0.05B $0.18B -33.22%
2014-03-31 $-0.06B $0.18B -45.78%
2013-12-31 $-0.04B $0.12B -36.29%
2013-09-30 $-0.04B $0.12B -32.84%
2013-06-30 $-0.04B $0.12B -43.58%
2013-03-31 $-0.01B $0.12B -7.49%
2012-12-31 $0.00B $0.12B -3.09%
2012-09-30 $-0.01B $0.00B -16.47%
2012-06-30 $-0.01B $0.13B -5.81%
2012-03-31 $-0.01B $0.14B -9.01%
2011-12-31 $-0.01B $0.07B -11.11%
2011-09-30 $0.00B $0.07B -4.08%
2011-06-30 $-0.01B $0.08B -10.74%
2011-03-31 $-0.01B $0.07B -12.33%
2010-12-31 $-0.01B $0.08B -10.56%
2010-09-30 $-0.02B $0.08B -21.12%
2010-06-30 $-0.02B $0.07B -19.83%
2010-03-31 $-0.02B $0.08B -18.58%
2009-12-31 $-0.01B $0.09B -12.77%
2009-09-30 $-0.01B $0.10B -9.63%
2009-06-30 $-0.01B $0.09B -8.77%
2009-03-31 $-0.01B $0.09B -7.51%
2008-12-31 $-0.01B $0.09B -12.40%
2008-09-30 $-0.01B $0.09B -14.14%
2008-06-30 $-0.02B $0.10B -20.44%
2008-03-31 $-0.03B $0.11B -30.77%
2007-12-31 $-0.04B $0.10B -35.32%
2007-09-30 $-0.04B $0.10B -35.10%
2007-06-30 $-0.04B $0.11B -35.45%
2007-03-31 $-0.03B $0.11B -30.36%
2006-12-31 $-0.04B $0.12B -30.70%
2006-09-30 $-0.04B $0.11B -30.11%
2006-06-30 $-0.04B $0.11B -30.71%
2006-03-31 $-0.04B $0.12B -28.96%
2005-12-31 $-0.03B $0.12B -19.96%
2005-09-30 $-0.02B $0.13B -10.66%
2005-06-30 $0.00B $0.14B 0.00%
2005-03-31 $0.01B $0.15B 5.17%
2004-12-31 $0.01B $0.15B 8.40%
2004-09-30 $0.01B $0.13B 5.54%
2004-06-30 $0.00B $0.12B 1.94%
2004-03-31 $0.00B $0.13B 2.56%
2003-12-31 $0.00B $0.13B -7.69%
2003-09-30 $-0.01B $0.03B -23.08%
2003-06-30 $0.00B $0.02B -8.60%
2003-03-31 $0.00B $0.02B 0.00%
2002-12-31 $0.00B $0.02B 26.67%
2002-09-30 $0.00B $0.02B 54.55%
2002-06-30 $0.00B $0.00B 0.00%
2002-03-31 $0.00B $0.00B 0.00%
2001-12-31 $0.00B $0.00B 0.00%
2001-09-30 $-0.01B $0.00B 0.00%
2001-06-30 $-0.01B $0.00B 0.00%
2001-03-31 $-0.01B $0.00B 0.00%
2000-12-31 $-0.01B $0.00B 0.00%
2000-09-30 $-0.01B $0.00B -160.00%
2000-06-30 $-0.01B $0.00B -213.33%
2000-03-31 $-0.01B $0.00B -266.67%
1999-12-31 $-0.01B $0.02B -60.00%
1999-06-30 $-0.01B $0.00B -160.00%
1999-03-31 $-0.01B $0.00B -144.00%
1998-12-31 $-0.01B $0.03B -128.00%
1998-09-30 $-0.01B $0.00B 0.00%
1998-06-30 $-0.01B $0.00B 0.00%
1998-03-31 $-0.01B $0.00B 0.00%
1997-12-31 $-0.01B $0.00B 0.00%
1997-09-30 $-0.01B $0.00B -120.00%
1997-06-30 $-0.01B $0.00B -93.33%
1997-03-31 $-0.01B $0.00B -93.33%
1996-12-31 $-0.01B $0.03B -80.00%
1996-09-30 $-0.01B $0.00B -600.00%
1996-06-30 $-0.01B $0.00B -700.00%
1996-03-31 $-0.01B $0.00B -600.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.816B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $78.129B 29.67
Zoetis (ZTS) United States $52.791B 18.89
Takeda Pharmaceutical (TAK) Japan $43.625B 8.90
Daiichi Sankyo, - (DSNKY) Japan $40.634B 20.24
BeOne Medicines - (ONC) Switzerland $36.101B 191.40
Sandoz Group AG (SDZNY) Switzerland $29.630B 0.00
United Therapeutics (UTHR) United States $19.545B 17.20
Merck (MKKGY) Germany $16.472B 10.71
Neurocrine Biosciences (NBIX) United States $14.958B 35.89
Shionogi (SGIOY) Japan $14.547B 13.36
Summit Therapeutics (SMMT) United States $14.112B 0.00
IPSEN (IPSEY) France $12.438B 0.00
Ionis Pharmaceuticals (IONS) United States $11.264B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.262B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.283B 0.00
Corcept Therapeutics (CORT) United States $7.941B 85.78
Stevanato Group S.p.A (STVN) Italy $7.344B 41.10
Grifols, S.A (GRFS) Spain $5.913B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.389B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.606B 17.13
Centessa Pharmaceuticals (CNTA) United Kingdom $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.983B 22.43
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.650B 8.45
Dyne Therapeutics (DYN) United States $2.644B 0.00
Soleno Therapeutics (SLNO) United States $2.487B 0.00
Ocular Therapeutix (OCUL) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.963B 23.27
Guardian Pharmacy Services (GRDN) United States $1.884B 36.28
BioCryst Pharmaceuticals (BCRX) United States $1.516B 90.00
Collegium Pharmaceutical (COLL) United States $1.376B 6.81
Ardelyx (ARDX) United States $1.373B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.338B 0.00
Xeris Biopharma Holdings (XERS) United States $1.281B 0.00
Harrow (HROW) United States $1.263B 77.59
Nektar Therapeutics (NKTR) United States $1.179B 0.00
Oruka Therapeutics (ORKA) United States $1.161B 0.00
Enliven Therapeutics (ELVN) United States $1.108B 0.00
Relay Therapeutics (RLAY) United States $1.069B 0.00
Evotec AG (EVO) Germany $1.062B 0.00
Xencor (XNCR) United States $0.981B 0.00
Cronos Group (CRON) Canada $0.980B 0.00
ARS Pharmaceuticals (SPRY) United States $0.878B 0.00
Organogenesis (ORGO) United States $0.830B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.759B 32.08
Savara (SVRA) United States $0.691B 0.00
Esperion Therapeutics (ESPR) United States $0.689B 0.00
Aquestive Therapeutics (AQST) United States $0.681B 0.00
Elite Pharmaceuticals (ELTP) United States $0.680B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.627B 5.60
Bioventus (BVS) United States $0.619B 12.69
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.466B 6.38
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Altimmune (ALT) United States $0.445B 0.00
Akebia Therapeutics (AKBA) United States $0.443B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.411B 9.73
USANA Health Sciences (USNA) United States $0.351B 9.79
Nature's Sunshine Products (NATR) United States $0.346B 20.60
Lyell Immunopharma (LYEL) United States $0.340B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Aldeyra Therapeutics (ALDX) United States $0.309B 0.00
Korro Bio (KRRO) United States $0.306B 0.00
Pyxis Oncology (PYXS) United States $0.297B 0.00
Larimar Therapeutics (LRMR) United States $0.294B 0.00
Achieve Life Sciences (ACHV) Canada $0.237B 0.00
Journey Medical (DERM) United States $0.235B 0.00
Aclaris Therapeutics (ACRS) United States $0.231B 0.00
OmniAb (OABI) United States $0.214B 0.00
AleAnna (ANNA) United States $0.214B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
Avalo Therapeutics (AVTX) United States $0.200B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Protara Therapeutics (TARA) United States $0.175B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.165B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.148B 0.00
Cassava Sciences (SAVA) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.126B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.118B 0.00
Context Therapeutics (CNTX) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.104B 0.00
Surrozen (SRZN) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
Champions Oncology (CSBR) United States $0.093B 33.90
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Gain Therapeutics (GANX) United States $0.090B 0.00
Unicycive Therapeutics (UNCY) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Lite Strategy (LITS) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.077B 0.00
Plus Therapeutics (PSTV) United States $0.077B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Prelude Therapeutics (PRLD) United States $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
BioNxt Solutions (BNXTF) Canada $0.062B 0.00
PolyPid (PYPD) Israel $0.059B 0.00
Talphera (TLPH) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.056B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
Inotiv (NOTV) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 24.75
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Heatwurx (PCSA) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ainos (AIMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.76
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00